Francis Collins, NIH director (Sean Zanni/Patrick McMullan via Getty Images)

NIH kicks off Covid-19 vac­cine, mon­o­clon­al an­ti­body re­search net­work

The NIH to­day an­nounced the kick­off of a na­tion­al clin­i­cal tri­als net­work to test vac­cines and oth­er treat­ments that could pre­vent in­fec­tion with SARS-CoV-2, the virus that caus­es in­fec­tion with Covid-19.

The net­work has been es­tab­lished by the Na­tion­al In­sti­tute of Al­ler­gy and In­fec­tious Dis­eases (NI­AID) through the merg­er of four pre­vi­ous­ly ex­ist­ing clin­i­cal tri­als net­works that fo­cused on HIV/AIDS.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.